6002

Lushang Freda Pharmaceutical Co.,Ltd. Stock Price

SHSE:600223 Community·CN¥8.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600223 Share Price Performance

CN¥7.86
0.81 (11.49%)
CN¥7.86
0.81 (11.49%)
Price CN¥7.86

600223 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

0 Risks
2 Rewards

Lushang Freda Pharmaceutical Co.,Ltd. Key Details

CN¥3.8b

Revenue

CN¥1.8b

Cost of Revenue

CN¥2.0b

Gross Profit

CN¥1.8b

Other Expenses

CN¥224.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 28, 2025
0.22
52.75%
5.83%
5.0%
View Full Analysis

About 600223

Founded
1993
Employees
3630
CEO
n/a
WebsiteView website
www.lshfreda.com

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It produces cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. It serves hospitals, primary medical institutions, and chain drug stores, etc. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. operates as a subsidiary of Shandong Freda Biological Co., Ltd.

Recent 600223 News & Updates

Recent updates

No updates